PATENT CLAIM ANALYSIS

Application Number: 16002441
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "575000"]

Abstract:
The present invention includes compositions for treating cancer, and methods using same. In certain embodiments, the compositions of the invention comprise a histone deacetylase inhibitor (HDACi), a cyclodextrin, water, optionally a polyalkylene glycol, and optionally dimethyl sulfoxide (DMSO). In other embodiments, the compositions of the invention comprise a HDACi, a cyclodextrin, water, a polyalkylene glycol, and DMSO.

Claim (Index 26):
The method of  claim 14 , wherein the subject is administered the composition through at least one route selected from the group consisting of nasal, inhalational, rectal, vaginal, pleural, peritoneal, parenteral, topical, transdermal, pulmonary, intranasal, buccal, ophthalmic, epidural, intrathecal, subcutaneous, and intravenous.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 94.0
- Lexical Diversity: 2.08333
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14737473', '15813582', '14451928', '15128977', '15998610']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7773690412622567
- 35 USC 102 Novelty (BERT): 0.5089022824021694
- Combined Prediction Score: 0.750522365376248
- Mean Citation Score: 214.736758
- Max Citation Score: 246.10732
- Similarity Product: 152.77175212740897

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test